Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump
24/7 Wall St. Abbott Laboratories (ABT) grew revenue 6.9% with medical devices up 14.8% to $5.45B. Abbott reaffirmed…
Baxter International Inc. (BAX): A Bull Case Theory
We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will summarize…